Molecular transduction mechanisms of cytokine-hormone interactions: Role of gp130 cytokines

Experimental Physiology

Volumn 92, Issue 5, 2007, Pages 801-806

  Gerez, Juan ^a   Bonfiglio, José ^a   Sosa, Sebastian ^a   Giacomini, Damiana ^a   Acuña, Matias ^a   Carbia Nagashima, Alberto ^a   Perone, Marcelo J ^a   Silberstein, Susana ^a   Renner, Ulrich ^b   Stalla, Günter K ^b   Arzt, Eduardo ^a  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR RECEPTOR; CORTICOTROPIN; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M; PROLACTIN; STEROID HORMONE;

ADENOHYPOPHYSIS; CELL GROWTH; CHRONIC INFLAMMATION; CONFERENCE PAPER; CORTICOTROPIN RELEASE; CYTOKINE PRODUCTION; ENDOCRINE SYSTEM; ENVIRONMENTAL CHANGE; GENETIC TRANSDUCTION; HORMONE SYNTHESIS; HUMAN; HUMORAL IMMUNITY; HYPOPHYSIS CELL; HYPOPHYSIS GONAD SYSTEM; HYPOTHALAMUS; IMMUNE SYSTEM; IMMUNITY; IMMUNOPATHOLOGY; NEUROENDOCRINE SYSTEM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 34548007879     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2007.036236     Document Type: Conference Paper

References (34)

1. Ahima RS (2006). Overcoming insulin resistance with CNTF. Nat Med 12, 511 512.
2. Akita S, Conn PM & Melmed S (1996a). Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function. J Clin Endocrinol Metab 81, 4170 4178.
3. Akita S, Malkin J & Melmed S (1996b). Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion. Endocrinology 137, 3140 3143.
4. Arzt E (2001). gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways. J Clin Invest 108, 1729 1733.
5. Arzt E, Buric R, Stelzer G, Stalla J, Sauer J, Renner U & Stalla GK (1993). Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology 132, 459 467.
6. Arzt E, Pereda MP, Castro CP, Pagotto U, Renner U & Stalla GK (1999). Pathophysiological role of the cytokine network in the anterior pituitary gland. Front Neuroendocrinol 20, 71 95.
7. Auernhammer CJ, Bousquet C & Melmed S (1999). Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci U S A 96, 6964 6969.
8. Auernhammer CJ & Melmed S (1999). Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis. Endocrinology 140, 1559 1566.
9. Ben-Shlomo A, Miklovsky I, Ren SG, Yong WH, Heaney AP, Culler MD & Melmed S (2003). Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells. J Clin Endocrinol Metab 88, 858 863.
10. Borg SA, Kerry KE, Baxter L, Royds JA & Jones TH (2003). Expression of interleukin-6 and its effects on growth of HP75 human pituitary tumor cells. J Clin Endocrinol Metab 88, 4938 4944.
11. Bousquet C, Susini C & Melmed S (1999). Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin by leukemia inhibitory factor. J Clin Invest 104, 1277 1285.
12. Bousquet C, Zatelli MC & Melmed S (2000). Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest 106, 1417 1425.
13. Carbia Nagashima AC, Giacomini D, Castro CP, Pereda MP, Renner U, Stalla GK & Arzt E (2003). Transcriptional regulation of interleukin-6 in pituitary folliculo-stellate TtT/GF cells. Mol Cell Endocrinol 201, 47 56.
14. Chesnokova V, Auerhamer CJ & Melmed S (1998). Murine LIF gene disruption attenuates the hypothalamio-pituitary-adrenal axis stress response. Endocrinology 139, 2209 2216.
15. Chesnokova V, Kariagina A & Melmed S (2002). Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation. Am J Physiol Endocrinol Metab 282, E1110 E1118.
16. Druker J, Liberman AC, Acuna M, Giacomini D, Refojo D, Silberstein S, Pereda MP, Stalla GK, Holsboer F & Arzt E (2006). Molecular understanding of cytokine-steroid hormone dialogue: implications for human diseases. Ann N Y Acad Sci 1088, 297 306.
17. Febbraio MA (2007). gp130 receptor ligands as potential therapeutic targets for obesity. J Clin Invest 117, 841 849.
18. Gloddek J, Lohrer P, Stalla J, Arzt E, Stalla GK & Renner U (2001). The intrapituitary stimulatory effect of lipopolysaccharide on ACTH secretion is mediated by paracrine-acting IL-6. Exp Clin Endocrinol Diabetes 109, 410 415.
19. Graciarena M, Carbia-Nagashima A, Onofri C, Perez-Castro C, Giacomini D, Renner U, Stalla GK & Arzt E (2004). Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model. Eur J Endocrinol 151, 595 604.
20. Hirano T (1994). Interleukin-6. In The Cytokine Handbook, ed. Thomson AW, pp. 145 168. Academic Press, Osaka, Japan.
21. Kariagina A, Zonis S, Afkhami M, Romanenko D & Chesnokova V (2005). Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis. Am J Physiol Endocrinol Metab 289, E857 E863.
22. Kurotani R, Yasuda M, Oyama K, Egashira N, Sugaya M, Teramoto A & Osamura RY (2001). Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas. Mod Pathol 14, 791 797.
23. Lohrer P, Gloddek J, Carbia Nagashima AC, Korali Z, Hopfner U, Páez Pereda M, Arzt E, Stalla GK & Renner U (2000). Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38a mitogen-activated protein kinase/nuclear factor-κB pathway. Endocrinology 141, 4457 4465.
24. Páez Pereda M, Lohrer P, Kovalovsky D, Perez Castro C, Goldberg V, Losa M, Chervín A, Berner S, Molina H, Stalla GK & Arzt E (2000). Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas. Exp Clin Endocrinol Diabetes 108, 202 207.
25. Perez Castro C, Carbia Nagashima AC, Pereda MP, Goldberg V, Chervin A, Largen P, Renner U, Stalla GK & Arzt E (2000). The gp130 cytokines interleukin-11 and ciliary neurotropic factor regulate through specific receptors the function and growth of lactosomatotropic and folliculostellate pituitary cell lines. Endocrinology 141, 1746 1753.
26. Perez Castro C, Carbia Nagashima AC, Paez Pereda M, Goldberg V, Chervín A, Carrizo G, Molina H, Renner U, Stalla GK & Arzt E (2001). Effects of the gp130 cytokines CNTF and IL-11 on pituitary cells: CNTF receptors on human pituitary adenomas and stimulation of PRL and GH secretion in normal rat anterior pituitary aggregate cultures. J Endo crinol 169, 539 547.
27. Perez Castro C, Giacomini D, Carbia Nagashima AC, Onofri C, Graciarena M, Kobayashi K, Paez-Pereda M, Renner U, Stalla GK & Arzt E (2003). Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells. Endocrinology 144, 693 700.
28. Shimon I, Yan X, Ray DW & Melmed S (1997). Cytokine dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J Clin Invest 100, 357 363.
29. Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, Fullmer KR & Bush RA (2006). Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A 103, 3896 3901.
30. Spangelo BL, Isakson PC & MacLeod RM (1990). Production of interleukin-6 by anterior pituitary cells is stimulated by increased intracellular adenosine 3′,5′-monophosphate and vasoactive intestinal peptide. Endocrinology 127, 403 409.
31. Stefana B, Ray DW & Melmed S (1996). Leukemia inhibitory factor (LIF) induces differentiation of pituitary corticotroph function: a neuro-endocrine phenotypic switch. Proc Natl Acad Sci U S A 93, 12502 12506.
32. Vankelecom H, Carmeliet P, Van Damme J, Billiau A & Denef C (1989). Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology 49, 102 106.
33. Wang Z, Ren SG & Melmed S (1996). Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology 137, 2947 2953.
34. Watt MJ, Dzamko N, Thomas WG, Rose-John S, Ernst M, Carling D, Kemp BE, Febbraio MA & Steimberg GR (2006). CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med 12, 541 548.